月經症候群治療市場規模、佔有率、成長分析（按產品、藥物類型、分銷管道和地區）- 產業預測（2025-2032）

預計2023年全球月經症候群治療市值將達13.9億美元，2032年將成長至18.9億美元，預測期間（2025-2032年）的複合年成長率為3.42%。

全球月經症候群 (PMS) 治療市場正在成長，這得益於人們對 PMS 及其對女性健康影響的認知不斷提高，以及對有效治療方案的需求不斷增加。隨著醫療保健趨勢強調個人化和非侵入性方法，人們明顯轉向非荷爾蒙和綜合治療。市場的主要參與者是知名的製藥和醫療保健公司，他們投資於研發以推出創新治療方法。然而，挑戰依然存在，包括延長治療機會的監管障礙和缺乏標準化的治療通訊協定，導致患者的治療結果不一致。包括 PMS 追蹤應用程式在內的數位健康解決方案的整合引發了人們對資料隱私和安全的擔憂，凸顯了隨著行業不斷發展，對強力資料保護的必要性。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與約束

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 案例研究
• 顧客購買行為分析

月經症候群治療市場規模（依產品及複合年成長率） (2025-2032)

• 市場概覽
• 處方箋
• 非處方藥

月經症候群治療市場規模（依藥物類型及複合年成長率） (2025-2032)

• 市場概覽
• 止痛藥
• 抗憂鬱症
• 口服避孕藥和卵巢抑制劑

月經症候群治療市場規模（依分銷管道及複合年成長率） (2025-2032)

• 市場概覽
• 藥局和藥房
• 醫院藥房
• 網路藥局

月經症候群治療市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 按部門分類的公司佔有率分析
  • 收益同比對比（2022-2024 年）

主要企業簡介

• Bayer AG
• Eli Lilly and Company
• GlaxoSmithKline Plc
• Pfizer Inc.
• AbbVie Inc.
• H. Lundbeck A/S
• Dr. Reddy's Laboratories Ltd
• BASF SE
• SHIONOGI & Co. Ltd
• Asarina Pharma AB
• Teva Pharmaceutical Industries Ltd
• Vistagen Therapeutics
• Herbalife International of America, Inc.
• The Nature's Bounty Co.
• Johnson & Johnson Services

結論和建議

Global Premenstrual Syndrome Treatment Market size was valued at USD 1.39 Billion in 2023 and is poised to grow from USD 1.44 Billion in 2024 to USD 1.89 Billion by 2032, growing at a CAGR of 3.42% in the forecast period (2025-2032).

The global premenstrual syndrome (PMS) treatment market is experiencing growth driven by heightened awareness of PMS and its impact on women's health, coupled with a demand for effective treatment options. There is a noticeable shift toward non-hormonal and integrative treatments, aligning with broader healthcare trends emphasizing personalization and non-invasive methods. Key players in the market comprise prominent pharmaceutical and healthcare companies investing in research and development to introduce innovative therapies. However, challenges persist, such as regulatory hurdles that prolong treatment accessibility and a lack of standardized treatment protocols, resulting in varied patient outcomes. The integration of digital health solutions, including PMS tracking apps, raises concerns about data privacy and security, underscoring the necessity for robust data protection as the industry continues to evolve.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Premenstrual Syndrome Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Premenstrual Syndrome Treatment Market Segments Analysis

The global premenstrual syndrome treatment market is segmented into product, drug, distribution channel, and region. by product, the market is classified into Prescription and Over-the-Counter (OTC). Depending on the drug, it is divided into Analgesics, Antidepressants, and Oral Contraceptives & Ovarian Suppression Agents. According to distribution channel, the market is categorized into Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Regionally, it is analyzed across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

Driver of the Global Premenstrual Syndrome Treatment Market

The growing awareness of premenstrual syndrome (PMS) through public education initiatives and awareness campaigns has significantly boosted diagnosis rates, leading to a heightened demand for treatments. Efforts by organizations focused on PMS have played a crucial role in informing women about the condition and its symptoms, encouraging them to seek medical assistance. This increased understanding not only helps women manage their symptoms more effectively but also drives the market for various treatments, including oral contraceptives, as more individuals become proactive in addressing their health needs related to PMS. This trend is crucial in expanding the overall premenstrual syndrome treatment market.

Restraints in the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome Treatment market faces significant restraints due to the stigma surrounding mental health issues associated with PMS and the prevalent underreporting of symptoms. In various cultures, there exists a taboo that discourages open discussions among women regarding their experiences and symptoms, which subsequently leads to a decreased demand for treatment options such as antidepressants and hormonal therapies. This lack of awareness and unwillingness to seek help hampers the overall growth potential of the market, as many individuals may not pursue the necessary interventions to alleviate their discomfort and improve their quality of life.

Market Trends of the Global Premenstrual Syndrome Treatment Market

The Global Premenstrual Syndrome (PMS) Treatment market is witnessing a significant shift towards natural and holistic solutions, as consumers increasingly prioritize plant-based remedies over conventional pharmaceuticals. This trend reflects a growing awareness of wellness and the desire for sustainable treatment options. Herbal supplements rich in vitamin B6, calcium, and magnesium are becoming popular choices for alleviating PMS symptoms like cramping and mood swings. As wellness trends continue to flourish, businesses that offer herbal and plant-based treatments are capitalizing on this demand, positioning themselves favorably within a market that seeks effective, drug-free solutions to improve women's health.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Customer Buying Behavior Analysis

Global Premenstrual Syndrome Treatment Market Size by Product & CAGR (2025-2032)

• Market Overview
• Prescription
• Over-the-Counter (OTC)

Global Premenstrual Syndrome Treatment Market Size by Drug Type & CAGR (2025-2032)

• Market Overview
• Analgesics
• Antidepressants
• Oral Contraceptives & Ovarian Suppression Agents

Global Premenstrual Syndrome Treatment Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Drug Stores & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Premenstrual Syndrome Treatment Market Size & CAGR (2025-2032)

• North America (Product, Drug Type, Distribution Channel)
  • US
  • Canada
• Europe (Product, Drug Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Drug Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Drug Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Drug Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• H. Lundbeck A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. Reddy's Laboratories Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BASF SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHIONOGI & Co. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Asarina Pharma AB
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vistagen Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Herbalife International of America, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Nature's Bounty Co.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations